
No data
No data
No data
| CAS Number | 51953-14-1 |
| Catalog Number | AG00DKJL(AGN-PC-0OBMC8) |
| Chemical Name | Pyrimidine-2,4-diol |
| EC Number | 200-621-9 |
| IUPAC Name | 1H-pyrimidine-2,4-dione |
| InChI | InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8) |
| InChI Key | ISAKRJDGNUQOIC-UHFFFAOYSA-N |
| MDL Number | MFCD00068245 |
| Molecular Formula | C4H4N2O2 |
| Molecular Weight | 112.0868 |
| SMILES | Oc1ccnc(n1)O |
| UNII | 56HH86ZVCT |
| Synonyms | Uracil,
uracil,
66-22-8,
2,4-Dihydroxypyrimidine,
2,4(1H,3H)-Pyrimidinedione,
2,4-Pyrimidinediol,
pyrimidine-2,4(1H,3H)-dione,
2,4-Dioxopyrimidine,
2,4-Pyrimidinedione,
Pirod,
Pyrod,
pyrimidine-2,4-diol,
Hybar X,
1H-Pyrimidine-2,4-dione,
51953-14-1,
RU 12709,
Ura,
Uracil [USAN],
1,2,3,4-tetrahydropyrimidine-2,4-dione,
CCRIS 3077,
Urazil,
2-Hydroxy-4(3H)-pyrimidinone,
SQ 6201,
SQ 7726,
SQ 8493,
BMS 205603-01,
AI3-25470,
UNII-56HH86ZVCT,
NSC 3970,
MFCD00006016,
2,4-Pyrimidinediol (9CI),
C4H4N2O2,
2-Hydroxy-4(1H)-pyrimidinone,
CHEBI:17568,
EINECS 200-621-9,
pyrimidinedione,
56HH86ZVCT,
4-Hydroxy-2(1H)-pyrimidinone,
NSC3970,
ISAKRJDGNUQOIC-UHFFFAOYSA-N,
4(3H)-Pyrimidinone, 2-hydroxy-,
66255-05-8,
SQ-6201,
SQ-7726,
SQ-8493,
Uracil-5-d,
NCGC00181030-01,
BMS-205603-01,
Uracil, 99+%,
DSSTox_CID_1424,
DSSTox_RID_76153,
DSSTox_GSID_21424,
4-Hydroxyuracil,
CAS-66-22-8,
Uracil (8CI),
Uracil [USAN:JAN],
Uracyl,
8h-uracil,
hydroxypyrimidinone,
2,6-Dioxypyrimidin,
Uracil,(S),
2,4-Dioxypyrimidine,
2,4(1H,3H)-Pyrimidinedione (9CI),
24897-50-5,
PubChem14135,
Uracil, 99%,
1ui0,
Uracil (JAN/USAN),
2,3H)-Pyrimidinedione,
4(1H)-Pyrimidinone, 2-hydroxy- (9CI),
4(3H)-Pyrimidinone, 2-hydroxy- (9CI),
2,6-Dihydroxypyrimidine,
2-oxy-4-oxy pyrimidine,
AC1Q6GOT,
2,4-?Dihydroxypyrimidine,
ACMC-1AS5O,
ACMC-1C4TI,
bmse000187,
bmse000940,
CHEMBL566,
Epitope ID:120356,
NCIMech_000782,
AC1L1AW5,
AC1Q1GU8,
SCHEMBL8235,
Uracil, >=99.0%,
144104-68-7,
51953-20-9,
66224-60-0,
KSC352S4R,
MLS001304993,
tetrahydropyrimidine-2,4-dione,
GTPL4560,
2,4-(1h,3h)-pyrimidinedione,
DTXSID4021424,
CTK1G3699,
CTK1G8296,
CTK1I0613,
CTK1J5004,
CTK2F2948,
Uracil, >=99.0% (T),
1,3-dihydropyrimidine-2,4-dione,
HMS2234E19,
HMS3264C13,
HMS3373E18,
HMS3652N05,
Pharmakon1600-01502345,
ZINC895045,
2(1H)-Pyrimidinone, 4-hydroxy-,
2(1H)-Pyrimidinone, 6-hydroxy-,
BCP26546,
HY-I0960,
NSC-3970,
NSC29742,
Tox21_112680,
Tox21_201023,
ANW-31373,
ANW-35165,
BBL004237,
CCG-35866,
NSC-29742,
NSC759649,
s4177,
SBB058492,
STK301734,
STL124066,
AKOS000119989,
AKOS002303991,
Tox21_112680_1,
AM83913,
CCG-213042,
CS-W020104,
DB03419,
LS-7748,
MCULE-1147953020,
NSC-759649,
PS-5279,
RP18951,
KS-0000024N,
NCGC00181030-02,
NCGC00247663-01,
NCGC00258576-01,
Uracil, Vetec(TM) reagent grade, 98%,
4CN-0756,
AJ-24138,
AK-86824,
AN-23751,
CJ-04447,
NCI60_003718,
Pyrimidine-2,4(1H,3H)-dione (Uracil),
SC-09054,
SC-29470,
SMR000752912,
TL806199,
ZB014964,
AB0008404,
DB-030518,
TC-120118,
BB 0242167,
FT-0609769,
FT-0694063,
ST45061548,
SW220239-1,
U0013,
Uracil, suitable for cell culture, BioReagent,
4177-EP2270010A1,
4177-EP2270015A1,
4177-EP2272832A1,
4177-EP2275420A1,
4177-EP2281563A1,
4177-EP2287152A2,
4177-EP2292593A2,
4177-EP2295055A2,
4177-EP2295408A1,
4177-EP2295414A1,
4177-EP2295416A2,
4177-EP2295434A2,
4177-EP2295441A2,
4177-EP2295503A1,
4177-EP2298748A2,
4177-EP2298764A1,
4177-EP2298765A1,
4177-EP2298778A1,
4177-EP2298783A1,
4177-EP2303848A2,
4177-EP2305219A1,
4177-EP2305642A2,
4177-EP2305684A1,
4177-EP2305808A1,
4177-EP2305825A1,
4177-EP2311453A1,
4177-EP2311815A1,
4177-EP2311842A2,
4177-EP2316459A1,
C00106,
D00027,
M-6157,
X-2151,
AB00171810_03,
AB00171810_04,
AB00918623-05,
142257-EP2272848A1,
142257-EP2292593A2,
A835376,
AC-907/30002021,
I03-0056,
Z56889474,
F1796-0008,
E2FC11E5-1887-46DF-B415-82313CE9B2BD,
Uracil, United States Pharmacopeia (USP) Reference Standard,
Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard,
InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8,
Uracil, Pharmaceutical Secondary Standard; Certified Reference Material,
51953-19-6,
766-19-8,
Uracilo,
Xyfid,
Uracil topical,
Unknown Ligand,
24-Dioxopyrimidine,
2,4-pirimidinediol,
2 4-Pyrimidinediol,
2,4-pirimidinediona,
2 4-Pyrimidinedione,
2,4-Dioxopirimidine,
pyrimidine-2,4-dione,
24-Dihydroxypyrimidine,
uridine-5'-diphosphate,
2,4-Dihidroxipirimidine,
Uracil, 99% 50g,
D0Y0DG,
2 -Pyrimidinone,6-hydroxy-,
4 -Pyrimidinone,2-hydroxy-,
Pyrimidine-2,4-diol / Uracil,
CID1174,
2,4 (1h, 3h)-pirimidinaediona,
Uracil 99% for biochemistry 25gm,
C4-H4-N2-O2,
AR-1L7967,
Uracil, 98% - 100G 100g,
ACN-028655,
CS-T-46139,
ethyl 2-oxo-3-(pyridin-4-yl)propanoate,
2(1H)-Pyrimidinone, 6-hydroxy- (9CI),
B1863,
D014498,
103204-67-7,
4214-76-0,
8077-38-1,
UDP,
UNL,
|
| Complexity | 161 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 112.027g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 8 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 112.088g/mol |
| Monoisotopic Mass | 112.027g/mol |
| Rotatable Bond Count | 0 |
| Topological Polar Surface Area | 58.2A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.1 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

